Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACA | Q13085 | 2/20 | 0.35 |
| ▸ | FASN | P49327 | 7/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21361283 | 0.93 | CYP1A2 (0.41) | ACACAFASNCYP1A2TSHRMEN1 | |
| SCHEMBL24324819 | 0.91 | FASN (0.35) | ACACAFASNEGLN1CNR2P2RX7 | |
| SCHEMBL21361291 | 0.89 | FASN (0.37) | ACACAFASN | |
| SCHEMBL21361287 | 0.89 | IRAK4 (0.37) | ACACAFASNCYP2C9EGLN1CNR2 | |
| SCHEMBL24324693 | 0.88 | FASN (0.39) | FASNEGLN1CNR2 | |
| SCHEMBL24325170 | 0.88 | FASN (0.40) | FASNCYP2C9CNR2P2RX7PIK3CA | |
| SCHEMBL21361286 | 0.88 | IRAK4 (0.36) | ACACAFASNCYP2C9CNR2KCNJ1 | |
| SCHEMBL21361223 | 0.88 | JAK2 (0.37) | FASNCNR2P2RX7PIK3CAMTOR | |
| SCHEMBL21361301 | 0.87 | GRM5 (0.45) | ACACAFASNCYP2D6GRM5 | |
| SCHEMBL22908414 | 0.87 | CYP1A2 (0.41) | ACACAFASNCYP1A2TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220117228-A1 | SUBSTITUTED AZASPIRO-CYCLES AS HERBICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220117228-A1 | SUBSTITUTED AZASPIRO-CYCLES AS HERBICIDES | DDT, DHFR, CCNB3 | ACACA 1303/4885FASN 2143/4885CYP1A2 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.